4.6 Article

A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record

期刊

GENETICS IN MEDICINE
卷 15, 期 10, 页码 824-832

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/gim.2013.120

关键词

clinical decision support; clinical sequencing; decision support rules; electronic health record; electronic medical record; next-generation sequencing

资金

  1. National Institutes of Health [U01HG006507, U01HG00637, U01HG006500, U01HG606492, U01HG006487, U01HG006485, U01HG006546, KG100355, RC1LM010526, UL1RR02574, UL1TR000423, U01HL098188, 275200800001C-2-0-1]
  2. Susan G. Komen foundation
  3. Washington State Life Sciences Discovery Fund
  4. Northwest Institute for Genetic Medicine
  5. Dana-Farber Cancer Institute Leadership Council

向作者/读者索取更多资源

Purpose: Genome-scale clinical sequencing is being adopted more broadly in medical practice. The National Institutes of Health developed the Clinical Sequencing Exploratory Research (CSER) program to guide implementation and dissemination of best practices for the integration of sequencing into clinical care. This study describes and compares the state of the art of incorporating whole-exome and whole-genome sequencing results into the electronic health record, including approaches to decision support across the six current CSER sites. Methods: The CSER Medical Record Working Group collaboratively developed and completed an in-depth survey to assess the communication of genome-scale data into the electronic health record. We summarized commonalities and divergent approaches. Results: Despite common sequencing platform (Illumina) adoptions, there is a great diversity of approaches to annotation tools and workflow, as well as to report generation. At all sites, reports are human-readable structured documents available as passive decision support in the electronic health record. Active decision support is in early implementation at two sites. Conclusion: The parallel efforts across CSER sites in the creation of systems for report generation and integration of reports into the electronic health record, as well as the lack of standardized approaches to interfacing with variant databases to create active clinical decision support, create opportunities for cross-site and vendor collaborations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Genetics & Heredity

Harmonizing variant classification for return of results in the All of Us Research Program

Steven M. Harrison, Christina A. Austin-Tse, Serra Kim, Matthew Lebo, Annette Leon, David Murdock, Aparna Radhakrishnan, Brian H. Shirts, Marcie Steeves, Eric Venner, Richard A. Gibbs, Gail P. Jarvik, Heidi L. Rehm

Summary: The All of Us Research Program aims to accelerate research and improve healthcare by collecting data from one million people in the United States. Participants can choose to receive genome analysis results, including actionable findings for certain gene-disorder pairs. Four participating clinical laboratories conducted a prelaunch study to ensure consistent reporting of variant classifications, with 99.1% concordance and resolution of all reportability differences through reassessment and discussion. This approach will be maintained for continuous classification harmonization and consistent reporting within the program.

HUMAN MUTATION (2022)

Article Pathology

Automated Pharmacogenomic Reports for Clinical Genome Sequencing

Barbara J. Klanderman, Christopher Koch, Kalotina Machini, Shruti S. Parpattedar, Shruthi Bandyadka, Chiao-Feng Lin, Elizabeth Hynes, Matthew S. Lebo, Sami S. Amr

Summary: Clinical laboratories offering genome sequencing can provide pharmacogenomic findings to patients, which can help inform medication selection and dosing throughout the lifespan. The lmPGX pipeline offers a solution for seamlessly integrating pharmacogenomic results with genome reporting, addressing various challenges in reporting.

JOURNAL OF MOLECULAR DIAGNOSTICS (2022)

Article Biochemistry & Molecular Biology

Development of a clinical polygenic risk score assay and reporting workflow

Limin Hao, Peter Kraft, Gabriel F. Berriz, Elizabeth D. Hynes, Christopher Koch, Prathik Kumar, Shruti S. Parpattedar, Marcie Steeves, Wanfeng Yu, Ashley A. Antwi, Charles A. Brunette, Morgan Danowski, Manish K. Gala, Robert C. Green, Natalie E. Jones, Anna C. F. Lewis, Steven A. Lubitz, Pradeep Natarajan, Jason L. Vassy, Matthew S. Lebo

Summary: The first report from the GenoVA Study provides insights into the development of a clinical polygenic risk score assay and discusses the challenges of implementing and reporting the results. The study developed a clinical genotype array-based assay for multiple conditions and analyzed prospective samples to determine the frequency of high-risk polygenic risk scores. The research highlights the importance of developing resources and workflows for using polygenic risk score information in patient care.

NATURE MEDICINE (2022)

Article Multidisciplinary Sciences

Genome-wide analysis of somatic noncoding mutation patterns in cancer

Felix Dietlein, Alex B. Wang, Christian Fagre, Anran Tang, Nicolle J. M. Besselink, Edwin Cuppen, Chunliang Li, Shamil R. Sunyaev, James T. Neal, Eliezer M. Van Allen

Summary: We established a comprehensive map of somatic mutation events in the whole cancer genomes, representing 19 tumor types. We found that protein-coding events and noncoding events play different roles in tumors, and noncoding events may be potential drivers. We also discovered that XBP1 mutations primarily accumulate outside the gene's promoter and impact gene expression.

SCIENCE (2022)

Article Cardiac & Cardiovascular Systems

Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality

Aniruddh P. Patel, Jacqueline S. Dron, Minxian Wang, James P. Pirruccello, Kenney Ng, Pradeep Natarajan, Matthew Lebo, Patrick T. Ellinor, Krishna G. Aragam, Amit Khera

Summary: A genetic association study found that approximately 0.7% of participants carried pathogenic variants associated with inherited cardiomyopathy. These carriers are difficult to identify through imaging in clinical practice, but they have an increased risk of cardiovascular disease and all-cause mortality.

JAMA CARDIOLOGY (2022)

Editorial Material Oncology

A Process Framework for Ethically Deploying Artificial Intelligence in Oncology

Andrew Hantel, Dillon D. Clancy, Kenneth L. Kehl, Jonathan M. Marron, Eliezer M. Van Allen, Gregory A. Abel

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Genetics & Heredity

Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations

Tian Ge, Marguerite R. Irvin, Amit Patki, Vinodh Srinivasasainagendra, Yen-Feng Lin, Hemant K. Tiwari, Nicole D. Armstrong, Barbara Benoit, Chia-Yen Chen, Karmel W. Choi, James J. Cimino, Brittney H. Davis, Ozan Dikilitas, Bethany Etheridge, Yen-Chen Anne Feng, Vivian Gainer, Hailiang Huang, Gail P. Jarvik, Christopher Kachulis, Eimear E. Kenny, Atlas Khan, Krzysztof Kiryluk, Leah Kottyan, Iftikhar J. Kullo, Christoph Lange, Niall Lennon, Aaron Leong, Edyta Malolepsza, Ayme D. Miles, Shawn Murphy, Bahram Namjou, Renuka Narayan, Mark J. O'Connor, Jennifer A. Pacheco, Emma Perez, Laura J. Rasmussen-Torvik, Elisabeth A. Rosenthal, Daniel Schaid, Maria Stamou, Miriam S. Udler, Wei-Qi Wei, Scott T. Weiss, Maggie C. Y. Ng, Jordan W. Smoller, Matthew S. Lebo, James B. Meigs, Nita A. Limdi, Elizabeth W. Karlson

Summary: This study developed and validated a trans-ancestry PRS using multiple populations' T2D GWAS data, demonstrating its potential as a risk index in clinical settings among diverse patients.

GENOME MEDICINE (2022)

Article Genetics & Heredity

Informing variant assessment using structured evidence from prior classifications (PS1, PM5, and PVS1 sequence variant interpretation criteria)

Vineel Bhat, Ivan A. Adzhubei, James D. Fife, Matthew Lebo, Christopher A. Cassa

Summary: This study explores the potential of using evidence of pathogenicity from prior variant classifications in ClinVar to inform variant interpretation based on the ACMG/AMP clinical guidelines. The findings show that thousands of variants, including those in clinically actionable disease genes, have evidence of pathogenicity from existing variant classifications, accounting for 2.5% of nonsynonymous SNVs in ClinVar. These variants with evidence of pathogenicity have similar computational predictions and splicing effects as their associated pathogenic variants.

GENETICS IN MEDICINE (2023)

Article Genetics & Heredity

Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization

Anna C. F. Lewis, Emma F. Perez, Anya E. R. Prince, Hana R. Flaxman, Lizbeth Gomez, Deanna G. Brockman, Paulette D. Chandler, Benjamin J. Kerman, Matthew S. Lebo, Jordan W. Smoller, Scott T. Weiss, Carrie L. Blout Zawatksy, James B. Meigs, Robert C. Green, Jason L. Vassy, Elizabeth W. Karlson

Summary: This study investigates the responses of patients and primary care providers (PCPs) to different designs of polygenic risk scores (PRS) clinical reports. The findings suggest that both patients and PCPs prefer the continuous representation of PRS and offer recommendations for report design. PCPs see PRS information as a natural extension of their current practice, but the lack of evidence for clinical utility is a major challenge for PRS implementation.

GENOME MEDICINE (2022)

Article Health Care Sciences & Services

The Evolution of a Large Biobank at Mass General Brigham

Natalie T. Boutin, Samantha B. Schecter, Emma F. Perez, Natasha S. Tchamitchian, Xander R. Cerretani, Vivian S. Gainer, Matthew S. Lebo, Lisa M. Mahanta, Elizabeth W. Karlson, Jordan W. Smoller

Summary: The Mass General Brigham Biobank is a large repository of biospecimens and data aimed at supporting translational research on disease phenotypes. It has enrolled over 135,000 participants, generated genomic data on more than 65,000 participants, and served numerous institutional studies. However, it faces challenges in terms of funding sustainability, integration into clinical workflows, and promoting diversity and equity in research resources.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Genetics & Heredity

Returning integrated genomic risk and clinical recommendations: The eMERGE study

Jodell E. Linder, Aimee Allworth, Sarah T. Bland, Pedro J. Caraballo, Rex L. Chisholm, Ellen Wright Clayton, David R. Crosslin, Ozan Dikilitas, Alanna DiVietro, Edward D. Esplin, Sophie Forman, Robert R. Freimuth, Adam S. Gordon, Richard Green, Maegan Harden, Ingrid A. Holm, Gail P. Jarvik, Elizabeth W. Karlson, Sofia Labrecque, Niall J. Lennon, Nita A. Limdi, Kathleen F. Mittendorf, Shawn N. Murphy, Lori Orlando, Cynthia A. Prows, Luke Rasmussen, Laura Rasmussen-Torvik, Robb Rowley, Konrad Teodor Sawicki, Tara Schmidlen, Shannon Terek, David Veenstra, Digna R. Velez Edwards, Devin Absher, Noura S. Abul-Husn, Jorge Alsip, Hana Bangash, Mark Beasley, Jennifer E. Below, Eta S. Berner, James Booth, Wendy K. Chung, James J. Cimino, John Connolly, Patrick Davis, Beth Devine, Stephanie M. Fullerton, Candace Guiducci, Melissa L. Habrat, Heather Hain, Hakon Hakonarson, Margaret Harr, Eden Haverfield, Valentina Hernandez, Christin Hoell, Martha Horike-Pyne, George Hripcsak, Marguerite R. Irvin, Christopher Kachulis, Dean Karavite, Eimear E. Kenny, Atlas Khan, Krzysztof Kiryluk, Bruce Korf, Leah Kottyan, Iftikhar J. Kullo, Katie Larkin, Cong Liu, Edyta Malolepsza, Teri A. Manolio, Thomas May, Elizabeth M. McNally, Frank Mentch, Alexandra Miller, Sean D. Mooney, Priyanka Murali, Brenda Mutai, Naveen Muthu, Bahram Namjou, Emma F. Perez, Megan J. Puckelwartz, Tejinder Rakhra-Burris, Dan M. Roden, Elisabeth A. Rosenthal, Seyedmohammad Saadatagah, Maya Sabatello, Dan J. Schaid, Baergen Schultz, Lynn Seabolt, Gabriel Q. Shaibi, Richard R. Sharp, Brian Shirts, Maureen E. Smith, Jordan W. Smoller, Rene Sterling, Sabrina A. Suckiel, Jeritt Thayer, Hemant K. Tiwari, Susan B. Trinidad, Theresa Walunas, Wei-Qi Wei, Quinn S. Wells, Chunhua Weng, Georgia L. Wiesner, Ken Wiley, Josh F. eMERGE Consortium, Josh F. Peterson

Summary: To assess the risk of common, complex diseases, it is important to consider clinical risk factors as well as monogenic and polygenic risks, which can be reflected in family history. Returning risk information to individuals and providers can impact preventive healthcare and the use of prophylactic therapies for those at high genetic risk.

GENETICS IN MEDICINE (2023)

Article Genetics & Heredity

Genome screening, reporting, and genetic counseling for healthy populations

Selina Casalino, Erika Frangione, Monica Chung, Georgia MacDonald, Sunakshi Chowdhary, Chloe Mighton, Hanna Faghfoury, Yvonne Bombard, Lisa Strug, Trevor J. Pugh, Jared Simpson, Saranya Arnoldo, Navneet Aujla, Erin Bearss, Alexandra Binnie, Bjug Borgundvaag, Howard Chertkow, Marc Clausen, Marc Dagher, Luke Devine, David Di Iorio, Steven Marc Friedman, Chun Yiu Jordan Fung, Anne-Claude Gingras, Lee W. Goneau, Deepanjali Kaushik, Zeeshan Khan, Elisa Lapadula, Tiffany Lu, Tony Mazzulli, Allison McGeer, Shelley L. McLeod, Gregory Morgan, David Richardson, Harpreet Singh, Seth Stern, Ahmed Taher, Iris Wong, Natasha Zarei, Elena Greenfeld, Limin Hao, Matthew Lebo, William Lane, Abdul Noor, Jennifer Taher, Jordan Lerner-Ellis

Summary: Rapid advancements in genome sequencing technology have improved our understanding of the relationship between genes and human disease. This study collected blood samples from COVID-19 patients and performed genome sequencing to analyze the data. The researchers developed a comprehensive report that includes information on disease risks, genetic variants, and ancestry. They emphasize the importance of genetic counseling and offer counseling and referrals for clinically significant findings.

HUMAN GENETICS (2023)

Review Genetics & Heredity

Elective genomic testing: Practice resource of the National Society of Genetic Counselors

Carrie L. Blout Zawatsky, David Bick, Louise Bier, Birgit Funke, Matthew Lebo, Katie L. Lewis, Ekaterina Orlova, Emily Qian, Lauren Ryan, Marci L. B. Schwartz, Emily R. Soper

Summary: Genetic counseling for elective genomic testing (EGT) is becoming more common, which has the potential to detect genetic conditions before significant health impact. Pre- and post-test counseling for EGT require complete family and medical history, but there are special considerations due to uncertainties and lack of guidelines. This practice resource aims to provide guidance for genetic counselors and healthcare providers caring for adults seeking EGT counseling.

JOURNAL OF GENETIC COUNSELING (2023)

Article Genetics & Heredity

Laboratory perspectives in the development of polygenic risk scores for disease: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)

Honey V. Reddi, Hannah Wand, Birgit Funke, Michael T. Zimmermann, Matthew S. Lebo, Emily Qian, Brian H. Shirts, Ying S. Zou, Bing M. Zhang, Nancy C. Rose, Aya Abu-El-Haija

GENETICS IN MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Inference of Causal Relationships Between Genetic Risk Factors for Cardiometabolic Phenotypes and Female-Specific Health Conditions

Brenda Xiao, Digna Velez R. Edwards, Anastasia Lucas, Theodore Drivas, Kathryn Gray, Brendan Keating, Chunhua Weng, Gail P. Jarvik, Hakon Hakonarson, Leah Kottyan, Noemie Elhadad, Wei-Qi Wei, Yuan Luo, Dokyoon Kim, Marylyn Ritchie, Shefali Setia Verma

Summary: This study aimed to investigate the genetic overlap and impact of cardiometabolic traits on female-specific health conditions. The results showed that there is a significant association between cardiometabolic polygenic scores and certain female-specific health conditions.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Genetics & Heredity

Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina

Katerina S. Kucera, Beth Lincoln Boyea, Brooke Migliore, Sarah Nelson Potter, Veronica R. Robles, Oksana Kutsa, Heidi Cope, Katherine C. Okoniewski, Anne Wheeler, Catherine W. Rehder, Edward C. Smith, Holly L. Peay

Summary: Screening for elevated CK-MM levels in dried blood spots is a feasible method to identify newborns with DMD. Including specific cutoffs, repeat testing, and genetic sequencing can improve the accuracy and sensitivity of screening.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Preparing for the unexpected: Recommendations for returning secondary findings in late-stage cancer care

Madeline Currey, Ilana Solomon, Sarah Mcgraw, Jenny Shen, Francisco Munoz, Ernesto Sosa, Vanessa Puello-Lozano, Sam Wing, Lisa Lopez, Michelle Afkhami, Janine Lobello, Szabolcs Szelinger, Stacy W. Gray

Summary: This study conducted qualitative interviews with cancer patients and providers to identify gaps in clinical care and propose care delivery solutions for the return of secondary germline findings. The responses of patients varied depending on the amount of pre-test counseling they received, and providers identified insufficient clinic time as a major barrier to pretest education. Online support tools and standardized pre-test education models were favored by providers. There were differing perspectives on how pre-test education should be integrated into clinical workflows, but agreement on the inclusion of differences between somatic and germline testing, likelihood of medically actionable findings, and the possibility of being referred to a genetics provider.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Genome sequencing detects a wide range of clinically relevant copy-number variants and other genomic alterations

Kiely N. James, Shimul Chowdhury, Yan Ding, Sergey Batalov, Kelly Watkins, Yong Hyun Kwon, Lucitia Van Der Kraan, Katarzyna Ellsworth, Stephen F. Kingsmore, Lucia Guidugli

Summary: This study used genome sequencing to detect a wide range of copy-number variants (CNVs) and other non-single nucleotide variant/indel variant types. These genetic alterations accounted for 15.8% of reported variants, with deletions being the most common type. The study also found that additional genetic tests were ordered in some cases, but failed to report the variants detected by genome sequencing.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Physician services and costs after disclosure of diagnostic sequencing results in the NYCKidSeq program

Asem Berkalieva, Nicole R. Kelly, Ashley Fisher, Samuel F. Hohmann, Monisha Sebastin, Miranda Di Biase, Katherine E. Bonini, Priya Marathe, Jacqueline A. Odgis, Sabrina A. Suckiel, Michelle A. Ramos, Rosamond Rhodes, Noura S. Abul-Husn, John M. Greally, Carol R. Horowitz, Melissa P. Wasserstein, Eimear E. Kenny, Bruce D. Gelb, Bart S. Ferket

Summary: The study aims to understand the effects of returning diagnostic sequencing results on clinical actions and economic outcomes for pediatric patients with suspected genetic disorders. The results showed that patients with positive findings were more likely to receive specialist consultation, but there were no significant increases in overall physician services and costs. More large-scale studies are needed to confirm these findings.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Incidence, prevalence, age at diagnosis, and mortality in individuals with 45,X/46,XY mosaicism: A population-based registry study

Kirstine Stochholm, Camilla Holmgard, Shanlee M. Davis, Claus H. Gravholt, Agnethe Berglund

Summary: This study assessed the incidence, prevalence, and age at diagnosis of individuals with 45,X/46,XY mosaicism and described the associated mortality pattern. The study found an increasing incidence of 45,X/46,XY mosaicism in males and a stable incidence in females. Males were diagnosed at an older age than females. Additionally, 45,X/46,XY mosaicism was associated with increased all-cause mortality.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphism

Yunjia Chen, Ender Karaca, Nathaniel H. Robin, Dana Goodloe, Ali Al-Beshri, S. Joy Dean, Anna C. E. Hurst, Andrew J. Carroll, Fady M. Mikhail

Summary: This study confirms the association between DLG2 intragenic deletions and neurodevelopmental disorders, supports the haploinsufficiency of the DLG2 gene, and suggests a potential association between these deletions and congenital anomalies and dysmorphism.

GENETICS IN MEDICINE (2024)